Globus Medical (GMED) Asset Writedowns and Impairment (2011 - 2026)

Globus Medical (GMED) has 16 years of Asset Writedowns and Impairment data on file, last reported at $5.0 million in Q1 2026.

• Quarterly Asset Writedowns and Impairment fell 16.78% year-over-year to $5.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.2 million (down 65.0% YoY) and the FY2025 annual result came in at $10.2 million, down 56.24% from the prior year.
• Asset Writedowns and Impairment grew to $5.0 million in Q1 2026, from $4.9 million in the prior quarter.
• In the past five years, Asset Writedowns and Impairment ranged from a high of $8.5 million in Q2 2024 to a low of -$5.9 million in Q4 2022.
• A 5-year average of $2.5 million and a median of $3.2 million in 2023 frame the typical range for Asset Writedowns and Impairment.
• Annual changes were most pronounced in 2024 — Asset Writedowns and Impairment jumped 1410.58% — and 2025, when it plunged 219.29%.
• Tracing GMED's Asset Writedowns and Impairment over 5 years: stood at -$5.9 million in 2022, then surged by 89.37% to -$626000.0 in 2023, then jumped by 1244.57% to $7.2 million in 2024, then plunged by 31.44% to $4.9 million in 2025, then rose by 0.98% to $5.0 million in 2026.
• The last three Asset Writedowns and Impairment figures came in at $5.0 million (Q1 2026), $4.9 million (Q4 2025), and -$5.6 million (Q3 2025), per Business Quant data.